Candel Therapeutics (CADL)
US Market

Candel Therapeutics (CADL) Stock Price & Analysis


CADL Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.15 - $4.25
Previous Close$1.53
Average Volume (3M)30.62K
Market Cap
Enterprise Value$7.78M
Total Cash (Recent Filing)$59.26M
Total Debt (Recent Filing)$22.79M
Price to Earnings (P/E)-1.7
Sep 06, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.92
Shares Outstanding28,919,810
10 Day Avg. Volume15,518
30 Day Avg. Volume30,622
Standard Deviation0.23
Financial Highlights & Ratios
Price to Book (P/B)1.47
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue112.73
Enterprise Value/Gross Profit77.78
Enterprise Value/Ebitda-0.24
Price Target Upside422.88% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Candel Therapeutics’s price range in the past 12 months?
Candel Therapeutics lowest stock price was $1.15 and its highest was $4.25 in the past 12 months.
    What is Candel Therapeutics’s market cap?
    Currently, no data Available
    When is Candel Therapeutics’s upcoming earnings report date?
    Candel Therapeutics’s upcoming earnings report date is Sep 06, 2023 which is in 94 days.
      How were Candel Therapeutics’s earnings last quarter?
      Candel Therapeutics released its earnings results on May 11, 2023. The company reported -$0.3 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.05.
        Is Candel Therapeutics overvalued?
        According to Wall Street analysts Candel Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Candel Therapeutics pay dividends?
          Candel Therapeutics does not currently pay dividends.
          What is Candel Therapeutics’s EPS estimate?
          Candel Therapeutics’s EPS estimate is -$0.3.
            How many shares outstanding does Candel Therapeutics have?
            Candel Therapeutics has 28,919,810 shares outstanding.
              What happened to Candel Therapeutics’s price movement after its last earnings report?
              Candel Therapeutics reported an EPS of -$0.3 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went down -3.371%.
                Which hedge fund is a major shareholder of Candel Therapeutics?
                Among the largest hedge funds holding Candel Therapeutics’s share is Woodline Partners LP. It holds Candel Therapeutics’s shares valued at N/A.


                  Candel Therapeutics Stock Smart Score

                  The Candel Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Candel Therapeutics

                  Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.


                  Top 5 ETFs holding CADL

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold CADL. The ETFs are listed according to market value of CADL within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  RAPT Therapeutics
                  Molecular Templates
                  Frequency Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis